SCHEMBL479891

SCHEMBL479891

COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(C(C)(C)N)c(NS(C)(=O)=O)c1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 1/20 0.37
BRD4 O60885 4/20 0.37
BRD2 P25440 2/20 0.37
KMT2A Q03164 5/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 2/20 0.36
MAPK10 P53779 1/20 0.36
MAPK14 Q16539 1/20 0.35
CDK2 P24941 2/20 0.35
CDK1 P06493 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19133985 1.00 HTT (0.41) HTTPOLBSMN1; SMN2KDM4EHSD17B10
SCHEMBL19133990 0.92 RXFP1 (0.41) POLBSMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL480560 0.92 RXFP1 (0.41) POLBSMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL480718 0.89 KMT2A (0.38) POLBBRD4BRD2KMT2ACTDSP1
SCHEMBL480655 0.86 KMT2A (0.40) POLBBRD4BRD2KMT2ACTDSP1
SCHEMBL2121532 0.86 KMT2A (0.40) POLBSMN1; SMN2BRD4BRD2KMT2A
SCHEMBL479595 0.85 BRD4 (0.40) POLBKDM4EBRD4BRD2KMT2A
SCHEMBL479448 0.85 KMT2A (0.39) POLBKMT2ACTDSP1TP53THRB
SCHEMBL479436 0.85 MAPT (0.40) POLBSMN1; SMN2KDM4EKMT2ACTDSP1
SCHEMBL479616 0.85 NOTUM (0.40) POLBKMT2ACTDSP1TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF HTT 331/4885POLB 3559/4885SMN1; SMN2 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.